Series A - Dauntless Pharmaceuticals

Series A - Dauntless Pharmaceuticals

Investment Firm

Overview

Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.

Announced Date

Feb 16, 2017

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Canaan Partners

Canaan Partners

Canaan Partners is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

2

Investor Name
Participant InvestorSofinnova Investments
Participant InvestorCanaan Partners

Round Details and Background

Dauntless Pharmaceuticals raised $25000000 on 2017-02-16 in Series A

Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2016
Series A - Dauntless Pharmaceuticals
1-undefined
Feb 16, 2017
Series A - Dauntless Pharmaceuticals
2-25.0M
Jul 21, 2015
Series A - Dauntless Pharmaceuticals
1-12.0M
Jun 10, 2015
Venture Round - Dauntless Pharmaceuticals
-3.0M

Recent Activity

There is no recent news or activity for this profile.